(-)-Bay k 8644 induces contraction in rat aorta by releasing an endothelium-derived contractant factor, likely a cyclo-oxygenase product.
Answers are grounded in this paper and cite their sources.
Endothelium-dependent contraction via COX products in rat aorta is hypothesis-generating; leaves open relevance to human vascular tone or therapy.
The contractile activity of (-)-Bay k 8644 was assessed in rat isolated aortic ring preparations bathed in a potassium-free medium. (-)-Bay k 8644 (0.01-3 microM) caused extracellular calcium-dependent contractile responses, which were significantly greater in tissues with, than deprived of a functional endothelium. In preparations with an endothelium, the contraction was attenuated by quinacrine (1 microM), indomethacin (10 microM) and diclofenac (0.1 microM), but not changed by nordihydroguaiaretic acid (30 microM) or dazoxiben (10 microM). Thus, in the rat aorta bathed in K(+)-free medium, (-)-Bay k 8644 can cause contractile effects, apparently due to the release of an endothelium-derived contractant factor (EDCF) which is proposed to be a cyclo-oxygenase product.
No takes yet. Share an insight, caveat, or question.
Lawson et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: